Open an account

Grifols SA

GIFLF · BOLSA

$10.55+$0.7124 (+7.24%)TodayMarket closed ·
No price history for this range.

About GIFLF

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. The company is headquartered in Sant Cugat Del Valles, Barcelona and currently employs 25,258 full-time employees. The company went IPO on 2006-05-17. The firm organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

Employees
25,258
Headquarters
Sant Cugat del Valles, Barcelona
Listed
May 17, 2006
Sector
Health Care
Industry
Biotechnology
Website
grifols.com

GIFLF key statistics

Market cap
6.01B
Price-earnings ratio
0.00
Dividend yield
2.13%
Average volume
9.70K
Volume
19
Open price
$10.55
High today
$10.55
Low today
$10.55
52 Week high
$12.90
52 Week low
$10.13

Grifols SA (GIFLF) at a glance

As of Oct 15, 2026, Grifols SA (GIFLF) shares are priced at $10.55, giving the company a market cap of 6.01B, a price-to-earnings ratio of 0.00 and a dividend yield of 2.13%.

Volume so far is 19 shares, below the average of 9.70K shares a day.

Over the past year Grifols SA has ranged from $10.13 to $12.90, and now sits 15% of the way up that range.

Grifols SA met or beat analyst EPS estimates in 3 of the last 6 quarters. In Q2 FY26 it reported $0.33 per share against an estimate of $0.1313.

GIFLF earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 6 quarters, by 80.4% on average.

  1. Q2 FY22: reported $0.29 per share against an estimate of $0.3182
  2. Q4 FY22: reported $0.05 per share against an estimate of $0.2828
  3. Q2 FY23: reported $0.17 per share against an estimate of $0.4141
  4. Q2 FY25: reported $0.29 per share against an estimate of $0.1616
  5. Q4 FY25: reported $0.223 per share against an estimate of $0.202
  6. Q2 FY26: reported $0.33 per share against an estimate of $0.1313

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.